• Drug Coverage
  • Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Safety & Recalls
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Reasons for attending the AAD meeting | AAD 2024


John Barbieri, assistant professor at Harvard Medical School, is looking forward to the upcoming 2024 American Academy of Dermatology meeting, which runs from March 8-12 in San Diego. Barbieri is particularly showing interest in late-breaking abstracts and trial data and hoping to see cutting-edge information from pivotal clinical trials.

John Barbieri, M.D., MBA, is one of the more 17,000 dermatologists and others attending the American Academy of Dermatology’s annual meeting this weekend in San Diego.

Barbieri, an assistant professor at Harvard Medical School, says he is looking forward to the fresh troves of data and the connecting with colleagues.

“I love seeing the new trial data as it comes out, and the late breaking research sessions are a good place to find those,” Barbieri said in a recent interview. “I also find that AAD is a great time to connect with colleagues. I think that's one of the best parts of this meeting is being able to see all of our colleagues in dermatology to think about how we can collaborate, to think about how we can move the field forward together.”

Barbieri specializes in inflammatory skin disease such as acne, rosacea, psoriasis and atopic dermatitis. He is the director of the Advanced Acne Therapeutics Clinic at the Harvard-affiliated Brigham and Women’s Hospital in Boston and is the co-chair of the academy’s acne guidelines work group.

He is speaking at four sessions at the meeting, which started today and ends on Tuesday. The sessions he is speaking are titled Great Care for Common Conditions: Combining Evidence and Cost Effectiveness; JAAD [Journal of the American Academy of Dermatology] game changers; Controversies in Acne and Rosacea; and Translating Evidence Into Practice: Acne Guidelines and Beyond.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.